MedPath

Effectiveness of a Psychoeducational Group Intervention in Patients With Depression and Physical Comorbidity

Not Applicable
Conditions
Depressive Disorder
Interventions
Behavioral: Group psychoeducation
Registration Number
NCT03243799
Lead Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Brief Summary

The primary aim is to evaluate the effectiveness of an intervention based on a psychoeducational program carried out by primary care nurses, to improve the rate of remission and response of depression in patients with physical chronic illness (diabetes, COPD, asthma and / or ischemic heart disease). Secondarily, to assess the cost-effectiveness of the intervention, the effectiveness to improve the control of physical pathology, the impact on quality of life and the feasibility of the intervention.

Methods: a multicentre, randomized clinical trial, with two groups and 1 year follow-up evaluation. Economic evaluation study. We will study 504 patients (252 in each group), over 50 years assigned to 25 primary care teams (PC) from Catalonia (urban, semi-urban and rural) with major depression and with at least one of the diseases: diabetes mellitus type 2, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease. They will be distributed randomly into two groups. The intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from PC, consisting of health education on chronic physical illness and depressive symptoms.

Main measurements: clinical remission of depression and / or response to intervention (Beck depression inventory: BDI-II). Secondary measures: improvement in control of chronic disease (blood test and physical parameters), drug compliance (test Morinsky-Green and number of packaging), quality of life (EQ-5D), medical service utilization (appointments and hospital admissions due to complications) and feasibility of the intervention (satisfaction and compliance). Evaluations will be masked and conducted at 0, 3 and 12 months. At 6 months, patients will receive a call from nurses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
504
Inclusion Criteria
  • Presence of at least one of the following diseases: type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, and / or ischemic heart disease.
  • Meet major depression criteria at the time of the study: Score above 13 on the BDI-II scale.
  • Possibility of follow-up of one year by the same primary care team.
  • At least read and write Spanish or Catalan.
Exclusion Criteria
  • Diagnosis of dementia or moderate or high cognitive impairment (5 or more errors according to the pfeiffer scale).
  • Major depression with psychotic symptoms or with other serious psychiatric comorbidities.
  • Moderate or high risk of suicide (6 or more points on the MINI suicide scale).
  • Dependency disorders due to alcohol or other drug abuse.
  • Advanced stage physical disease.
  • Inability to travel to the center.
  • Be receiving some psychological therapy by the Center of mental health (CSM) of reference

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupGroup psychoeducationThe intervention group will participate in psychoeducational groups: 12 weekly 90-minute sessions led by two nurses from Primary Care, consisting of health education on chronic physical illness and depressive symptoms. Group psychoeducation.
Primary Outcome Measures
NameTimeMethod
Changes in rate of remission of depressionAt 12 months of follow-up

Changes in the score of the BDI-II scale

Secondary Outcome Measures
NameTimeMethod
Changes in rate of remission of depressionAt 3 months of follow-up

Changes in the score of the BDI-II scale

Changes in the control of asthmaAt 12 months of follow-up

Changes in FEV1

Changes in the control of Ischemic heart diseaseAt 12 months of follow-up

Changes in LDL cholesterol

Satisfaction with the interventionAt 3 months of follow-up

Survey at the end of the intervention

Adherence to the interventionAt 3 months of follow-up

Number of assisted sessions

Changes in the control of COPDAt 12 months of follow-up

Changes in FEV1

Quantification of the use of servicesAt 12 months of follow-up

Number of hospital admissions

Qualitative changes of the state of health at the end of the interventionAt 3 and 12 months of follow-up

better, equal or worse

Changes in the control of DM2At 12 months of follow-up

Changes in HbA1c

Record of therapeutic complianceAt 12 months of follow-up

Morisky-Green test

Referrals to mental healthAt 12 months of follow-up

Number of visits to mental health centers

Changes in the quality of lifeAt 12 months of follow-up

Measured by the EuroQol scale (EQ-5D)

Qualitative changes of the state of mind at the end of the interventionAt 3 and 12 months of follow-up

better, equal or worse

Trial Locations

Locations (1)

Centre d'Atenció Primària (CAP) Santa Margarida de Montbui

🇪🇸

Santa Margarida de Montbui, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath